Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells

被引：0

作者：

Johnson, N. ^{[1
,2
]}

Bentley, J. ^{[1
]}

Wang, L-Z ^{[1
]}

Newell, D. R. ^{[1
]}

Robson, C. N. ^{[1
]}

Shapiro, G. I. ^{[2
]}

Curtin, N. J. ^{[1
]}

机构：

[1] Newcastle Univ, Northern Inst Canc Res, Paul OGorman Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, England

[2] Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA

来源：

BRITISH JOURNAL OF CANCER | 2024年

关键词：

D O I：

10.1038/s41416-024-02813-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：955 / 955

页数：1

共 50 条

[21] Flavopiridol induces G(1) arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells
Carlson, BA
Dubay, MM
Sausville, EA
Brizuela, L
Worland, PJ
CANCER RESEARCH, 1996, 56 (13) : 2973 - 2978
[22] Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma
Wang, J. -J.
Fang, Z. -X.
Ye, H. -M.
You, P.
Cai, M. -J.
Duan, H. -B.
Wang, F.
Zhang, Z. -Y.
DISEASES OF THE ESOPHAGUS, 2013, 26 (07) : 729 - 736
[23] NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Ma, Cynthia X.
Gao, Feng
Luo, Jingqin
Northfelt, Donald W.
Goetz, Matthew
Forero, Andres
Hoog, Jeremy
Naughton, Michael
Ademuyiwa, Foluso
Suresh, Rama
Anderson, Karen S.
Margenthaler, Julie
Aft, Rebecca
Hobday, Timothy
Moynihan, Timothy
Gillanders, William
Cyr, Amy
Eberlein, Timothy J.
Hieken, Tina
Krontiras, Helen
Guo, Zhanfang
Lee, Michelle V.
Spies, Nicholas C.
Skidmore, Zachary L.
Griffith, Obi L.
Griffith, Malachi
Thomas, Shana
Bumb, Caroline
Vij, Kiran
Bartlett, Cynthia Huang
Koehler, Maria
Al-Kateb, Hussam
Sanati, Souzan
Ellis, Matthew J.
CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4055 - 4065
[24] Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Preclinical and Clinical Data
Vidula, Neelima
Rugo, Hope S.
CLINICAL BREAST CANCER, 2016, 16 (01) : 8 - 17
[25] Inhibition of Breast Cancer Resistance Protein (BCRP/ABCG2) by Purine Cyclin-dependent Kinase Inhibitors In Vitro and In Situ
Hofman, Jakub
Ahmadimoghaddam, Davoud
Hahnova, Lenka
Ceckova, Martina
Staud, Frantisek
DRUG METABOLISM REVIEWS, 2010, 42 : 33 - 33
[26] Parkin Enhances the Expression of Cyclin-dependent Kinase 6 and Negatively Regulates the Proliferation of Breast Cancer Cells
Tay, Shiam-Peng
Yeo, Calvin W. S.
Chai, Chou
Chua, Pei-Jou
Tan, Hui-Mei
Ang, Alex X. Y.
Yip, Daniel L. H.
Sung, Jian-Xiong
Tan, Puay Hoon
Bay, Boon-Huat
Wong, Siew-Heng
Tang, Carol
Tan, Jeanne M. M.
Lim, Kah-Leong
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (38) : 29231 - 29238
[27] Cyclin-dependent kinase inhibition and its intersection with immunotherapy in breast cancer: more than CDK4/6 inhibition
Guo, Xianan
Chen, Huihui
Zhou, Yunxiang
Shen, Lu
Wu, Shijie
Chen, Yiding
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (09) : 933 - 944
[28] Inhibition of cyclin-dependent kinase 1 (cdk1) by indirubin derivatives in human tumor cells.
Marko, D
Schätzle, S
Eisenbrand, G
CLINICAL CANCER RESEARCH, 1999, 5 : 3756S - 3756S
[29] Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells
Kilker, RL
Hartl, MW
Rutherford, TM
Planas-Silva, MD
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 92 (1-2): : 63 - 71
[30] Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers
Hur, Saem
Kim, Ju Hee
Yun, Jihui
Ju, Young Wook
Han, Jong Min
Heo, Woohang
Kim, Kwangsoo
Jeong, Kyeonghun
Lee, Han-Byoel
Han, Wonshik
Noh, Dong-Young
Hong, Dongwan
Moon, Hyeong-Gon
JOURNAL OF BREAST CANCER, 2020, 23 (02) : 162 - 170

← 1 2 3 4 5 →